Physics of Nuclear Medicine
Decay modes, particle emissions, LET, and half-life, the basis of imaging and therapy
Quick Answer
Radionuclides decay by emitting particles or photons whose properties determine whether an isotope is suited to imaging or therapy. Gamma and positron emitters (Tc-99m, F-18, Ga-68) are for imaging because their photons escape the body to a detector. Particle emitters — beta (β⁻) (Lu-177, Y-90, I-131) and alpha (α) (Ra-223, Ac-225) — deposit energy locally over millimeters or micrometers, which makes them therapeutic. Linear energy transfer (LET) and half-life are the two properties that most shape efficacy and radiation protection.
Why Physics Matters Clinically
A therapy-capable nuclear-medicine physician explains why a given isotope is chosen and how its dose is delivered. Decay mode sets the imaging/therapy role; LET sets biological potency; half-life sets logistics, retained activity, and patient-release rules. These physical properties are the foundation of every theranostic decision.
Radiation Quantities (Orientation)
- Activity — becquerel (Bq) / curie (Ci): decays per unit time.
- Absorbed dose — gray (Gy): energy per unit mass.
- Equivalent dose — sievert (Sv): absorbed dose weighted for radiation type (α weighted heavily).
- Effective dose — Sv: equivalent dose weighted by tissue radiosensitivity (compares whole-body stochastic risk).
Decay Modes
| Mode | Emission | Role | Examples |
|---|---|---|---|
| Isomeric transition | γ photon | Imaging (SPECT) | Tc-99m (140 keV) |
| Positron (β⁺) | positron → 511 keV annihilation photons | Imaging (PET) | F-18, Ga-68, Rb-82 |
| Electron capture | characteristic X-rays / γ | Imaging (SPECT) | I-123, Tl-201, In-111 |
| Beta minus (β⁻) | electron | Therapy (± imageable γ) | Lu-177, Y-90, I-131 |
| Alpha (α) | helium nucleus | Therapy | Ra-223, Ac-225, Pb-212 |
Particle Range & LET
- Beta particles travel millimeters (low-to-moderate LET), giving a useful crossfire effect across cell clusters — good for bulkier/heterogeneous disease. Lu-177 conveniently also emits an imageable γ (post-therapy SPECT/dosimetry).
- Alpha particles travel only a few cell diameters (micrometers) but carry very high LET, producing dense, clustered DNA double-strand breaks that are largely irreparable and relatively independent of oxygenation and dose rate. This makes alphas potent against micrometastatic/radioresistant disease, at the cost of harder dosimetry and daughter-nuclide concerns (e.g. Ac-225's recoiling progeny).
Half-Life & Decay
Physical half-life governs how quickly activity decays: A = A₀·e^(−0.693·t/t½). It sets pre-calibration/decay corrections and achievable protocols (Rb-82's 76-second half-life forces on-generator, pharmacologic-stress-only workflows). With biological clearance it yields the effective half-life that drives radiation dose and patient-release timing.
Effective Half-Life — the Number That Governs Dose
Radiation dose and patient-release timing depend on the effective half-life, not the physical one alone:
1/t½(eff) = 1/t½(physical) + 1/t½(biological)
A tracer that is physically long-lived but rapidly excreted delivers less dose than its physical half-life suggests, and vice versa.
Generator Equilibria (Preview)
Generators exploit parent→daughter decay: transient equilibrium (Mo-99 → Tc-99m; parent half-life somewhat longer than daughter) and secular equilibrium (very long-lived parent, e.g. Sr-82 → Rb-82 / Ge-68 → Ga-68). See the radiopharmaceuticals page for the practical elution logic.
Positron Range & PET Resolution
A positron travels a short distance before annihilation — positron range blurs the reconstructed location, larger for higher-energy emitters (Rb-82, Ga-68) than for F-18 (one reason F-18 agents look sharper). The two 511-keV photons are also not emitted at exactly 180° (a small angular deviation), adding a further, scanner-diameter-dependent resolution limit.
Choosing an Isotope — the Summary Logic
Imaging needs escaping photons (γ for SPECT, e.g. 140 keV for Tc-99m; positrons → 511 keV for PET); therapy needs locally deposited particle energy (β for mm-range crossfire, α for µm-range high-LET kill). Half-life sets logistics (generator vs cyclotron vs distribution) and, with biological clearance, dose to the patient and others. A single element can serve both ends of a theranostic pair when chemistry allows (Ga-68 image / Lu-177 treat on the same DOTA-conjugated ligand).
Board Pearls
Imaging isotopes must emit escaping photons; therapy isotopes must deposit particle energy locally — the same element can do both across a theranostic pair (e.g. Ga-68/Lu-177 on the same ligand). Radiation dose and patient-release timing depend on effective half-life, not physical half-life alone.
Alpha vs beta is the crux of the modern therapy conversation: alphas are high-LET, micrometer-range, oxygen/dose-rate-independent (potent against micrometastases, harder dosimetry, daughter-nuclide concerns); betas are mm-range with crossfire for bulkier disease.
Positron range blurs PET localization — larger for high-energy emitters (Rb-82, Ga-68) than F-18 — and the small non-180° annihilation-photon deviation adds a scanner-size-dependent limit. These physics set the resolution ceiling before any reconstruction choice. Effective half-life combines physical decay with biological clearance to determine actual dose.
Related Pages
- Calculators: decay and effective dose tools.
- Related: Radiopharmaceuticals & production, radiation detection & instrumentation, radiation biology & protection.
Figure / Diagram Suggestions
- A decay-mode chart mapping emission → imaging/therapy role.
- An α vs β range/LET comparison (µm high-LET vs mm crossfire).
- An effective half-life schematic (physical ⊕ biological clearance).
Self-Check (Board-Style)
Q1. Why are alpha emitters (e.g. Ac-225) attractive for micrometastatic disease despite harder dosimetry?
Answer: Their very high LET over a few-cell-diameter range produces dense, largely irreparable DNA double-strand breaks that are relatively independent of oxygenation and dose rate — potent against small, radioresistant deposits.
Q2. A radionuclide has a long physical half-life but is rapidly renally excreted. How does this affect patient dose?
Answer: Dose depends on the effective half-life (physical ⊕ biological clearance); rapid excretion shortens it, so the delivered dose is less than the physical half-life alone implies.
Q3. Why do F-18 PET images tend to look sharper than Ga-68 or Rb-82?
Answer: F-18's lower positron energy gives a shorter positron range (less blurring of the annihilation location) than higher-energy Ga-68/Rb-82.
Q4. What makes Lu-177 convenient for theranostics beyond its therapeutic beta?
Answer: It also emits an imageable gamma, enabling post-therapy SPECT and dosimetry on the same administration.
Evidence & sources
https://nuc.med/physics-nuclear-medicine/ Report an issue